Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects

Feeling low and depressed is a very common experience, affecting many people in the UK. Sometimes these feelings are part of Major Depressive Disorder, and sometimes they are part of Bipolar Disorder. Both conditions involve periods of depression, but Bipolar Disorder also includes periods of feeling extremely high or energetic. Diagnosing these two conditions correctly is really important because the treatments are quite different. Using antidepressants alone for someone with bipolar disorder can sometimes make their condition worse or even lead to harmful thoughts.

Unfortunately, it often takes a long time, sometimes many years, for someone with bipolar disorder to get the correct diagnosis. This delay can mean they don't get the most effective treatment for their condition and can face more difficulties, including a higher risk of self-harm. Doctors look for specific signs and symptoms to make a diagnosis, but it can still be tricky to tell the difference, especially when someone is only experiencing depression at the time.

This study is looking into a new blood test called EDIT-B®. The aim is to see if this test can help doctors quickly and accurately distinguish between Major Depressive Disorder and Bipolar Disorder when someone is going through a depressive episode. By getting a quicker and more accurate diagnosis, patients could receive the right treatment sooner, which could significantly improve their health and well-being. The study will also look at how this test might benefit the healthcare system as a whole.